Signaling pathways
-
BA3301 NemorosoneSummary: Nemorosone is the main component of the resin. - BA3302 PT-262Summary: PT-262 is a potent inhibitor with a value of approximately 5 μM.
- BA3303 DD1Summary: DD1 is a proteasome inhibitor activated during apoptosis in acute myeloid leukemia (AML) that degrades P70S6K.
- BA3304 GalgravinSummary: Galgravin is one of the active compounds in and has anti-inflammatory properties.
- BA3305 ZPCKSummary: ZPCK is a precursor of gemcitabine.
- BA3306 ToddaculinSummary: Toddaculin is a natural coumarin that induces differentiation and apoptosis in leukemia cells.
- BA3307 Thalidomide-O-C6-NHBocSummary: Thalidomide-O-C6-NHBoc is a synthetic E3 ligase ligand-linker coupler.
- BA3308 TJ191Summary: TJ191 is a potent anticancer agent targeting malignant T-cell leukemia/lymphoma cells with low TβRIII expression.
- BA3309 Thalidomide-O-C4-COOHSummary: Thalidomide-O-C4-COOH is a synthetic E3 ligase ligand-linker coupler.
- BA3310 MNK8Summary: MNK8 is a potent (signaling transducer and activator of transcription 3) inhibitor.